Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04065399
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2019-08-16
Brief Title:
A Study of Revumenib in RR Leukemias Including Those With an MLLKMT2A Gene Rearrangement or NPM1 Mutation
Sponsor:
Syndax Pharmaceuticals
Organization:
Syndax Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia |
| Acute Lymphoblastic Leukemia |
| Mixed Lineage Acute Leukemia |
| Mixed Phenotype Acute Leukemia |
| Acute Leukemia of Ambiguous Lineage |